Newer antisecretory agents for peptic ulcer.
D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D004298:Dopamine / Q000502:physiology; D018492:Dopamine Antagonists; D005750:Gastric Juice / Q000378:metabolism*; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use; D010437:Peptic Ulcer / Q000188:drug therapy*; D011453:Prostaglandins / Q000627:therapeutic use; D011619:Psychotropic Drugs / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D018492:Dopamine Antagonists; D006635:Histamine H2 Antagonists; D010276:Parasympatholytics; D011453:Prostaglandins; D011619:Psychotropic Drugs; D004298:Dopamine